In today’s fast-paced business environment, organizations must rely on accurate insights and structured data to remain competitive and sustainable. Recognizing this growing demand, Emergen Research has introduced its advanced Dural Adhesive Agent For Surgical market research content, a comprehensive solution designed to help businesses understand evolving market trends and make informed strategic decisions. This offering is built to support companies across various industries by providing meaningful insights and practical guidance.

A key strength of this research lies in its ability to simplify complex data into actionable knowledge. Businesses often struggle with interpreting large volumes of information, but this content is designed to present insights in a clear and structured manner. By focusing on usability, the report ensures that decision-makers can quickly understand the data and apply it effectively to their strategies.

The Dural Adhesive Agent for Surgical market size is expected to grow from 0.19 billion by the end of 2025 to 0.3 billion by 2033, registering a revenue CAGR of 5.60% during the forecast period.

The growth of the Dural Adhesive Agent for Surgical Market is propelled by the increasing incidence of neurosurgical procedures, rising demand for minimally invasive surgeries, and advancements in biocompatible adhesive technologies.

Furthermore, heightened awareness among healthcare professionals and regulatory approvals are facilitating broader market adoption. The increasing prevalence of spinal conditions, including herniated discs, spinal stenosis, and degenerative disc disease, is contributing to the rising volume of spinal surgeries, where dural adhesives play a critical role in preventing cerebrospinal fluid (CSF) leaks.

In 2022, approximately 47,000 implanted spinal procedures were performed across Southeast Asian (SEA) countries. Within this region, thoracolumbar fixation using rods and screws represents the largest market segment by value, accounting for approximately 42% of the total market.

Singapore and Thailand lead the SEA spinal market, representing approximately 60% of the total market value, driven by strong patient demand and a well-established medical tourism sector. The adoption of dural adhesives continues to expand in spinal decompression surgeries and laminectomies, supporting enhanced surgical precision and reduced recovery times.   

The increasing adoption of minimally invasive spine and brain surgeries is driving demand for advanced surgical materials that enhance procedural efficiency. Dural adhesives are gaining prominence due to their ability to provide secure closure, reduce cerebrospinal fluid (CSF) leaks, and improve patient outcomes.

The transition toward minimally invasive techniques is fostering investments in next-generation adhesive formulations with enhanced biocompatibility and adhesion properties. Furthermore, the growing utilization of robotic-assisted and image-guided neurosurgical procedures is accelerating the integration of dural adhesives into modern surgical workflows.

Another significant aspect of the Dural Adhesive Agent For Surgical market research content is its emphasis on continuous innovation and expert-driven analysis. The research is developed by a team of experienced professionals who possess a deep understanding of industry dynamics. Their insights help businesses uncover hidden opportunities, understand competitive pressures, and anticipate future challenges.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4536

The report also explores key drivers influencing the market’s growth. Factors such as technological advancements, changing consumer behavior, and economic developments play a crucial role in shaping the Dural Adhesive Agent For Surgical market. By analyzing these drivers, the report provides businesses with a clear understanding of what is fueling growth and how they can align their strategies accordingly.

By Application Outlook (Revenue, USD Billion; 2025-2033) 

• Cranial Surgery
• Spinal Surgery

By Type Outlook (Revenue, USD Billion; 2025-2033) 

• Polyethylene glycol
• Others (Fibrin Glue)

By Form Outlook (Revenue, USD Billion; 2025-2033) 

• Sealant Glue
• Sealant Film

By Regional Outlook (Revenue, USD Billion; 2025-2033) 

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Turkey
  • Rest of MEA

In addition to growth drivers, the report highlights the importance of strategic planning and adaptability. Businesses that remain flexible and responsive to market changes are more likely to succeed in a competitive landscape. Emergen Research ensures that its content reflects the latest market conditions, allowing organizations to stay updated and make timely decisions.

Market Segmentation:

The segmentation analysis included in the report provides valuable insights into different market categories. By examining various segments based on product types, applications, and end-user industries, businesses can identify high-potential areas and focus their efforts accordingly. This targeted approach helps improve efficiency and maximize returns.

Market competition in the Dural Adhesive Agent for Surgical industry is characterized by the presence of global and regional players such as Medprin, Integra LifeSciences Corporation, Pramand, LLC (CraniSeal), Stryker, and others.

Companies are actively investing in the development of advanced bioengineered adhesives designed to enhance sealing efficiency, optimize biocompatibility, and accelerate post-surgical healing.

Research and development (R&D) efforts are centered on both synthetic and biologically derived adhesive formulations that mitigate infection risks and contribute to improved patient outcomes.

Market participants must adhere to stringent regulatory standards set by authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other national healthcare regulatory bodies.

Organizations that emphasize innovation, regulatory compliance, and strategic market expansion are well-positioned to maintain a competitive advantage in this evolving industry.

In November 2025, Ethicon, a division of Johnson & Johnson MedTech, introduced Ethizia, a hemostatic sealing patch designed to effectively control bleeding during surgical procedures.

Some of the key companies in the global Dural Adhesive Agent for Surgical market include:

• Medprin
• Integra LifeSciences Corporation
• Pramand, LLC (CraniSeal)
• Stryker
• DuraStat, Inc
• Covidien (Medtronic)
• Becton
• Regenity
• Baxter
• Johnson & Johnson MedTech

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/4536

Competitive Landscape:

Understanding competition is another critical component of the research. The report offers a comprehensive analysis of the competitive landscape, highlighting key players and their strategies. It examines recent developments such as mergers, acquisitions, partnerships, and product innovations, providing businesses with valuable insights into how competitors are positioning themselves.

Increasing Number of Neurosurgeries

The rising incidence of traumatic brain injuries (TBIs), brain tumors, and spinal cord injuries is contributing to an increased volume of neurosurgical procedures, necessitating the use of dural adhesive agents.

A comprehensive study reported that more than three billion people worldwide were living with a neurological condition. Over 80% of neurological-related mortality and health loss occur in low- and middle-income countries, where disparities in access to treatment remain significant, with high-income countries having up to 70 times more neurological professionals per 100,000 people.

Additionally, the global prevalence of diabetic neuropathy has more than tripled since 1990, reaching 206 million cases in 2021. The aging population is further contributing to the increasing burden of neurological disorders, including Parkinson’s disease, Alzheimer’s, and strokes, which often require surgical interventions, driving greater demand for dural adhesives in neurosurgical applications.  

The Dural Adhesive Agent For Surgical market research content also includes a wide range of resources, including detailed reports, case studies, whitepapers, and trend analyses. These materials cover multiple industries such as healthcare, technology, finance, and manufacturing, making the content highly versatile and applicable across different sectors.

Another notable feature of the report is its focus on delivering actionable recommendations. Businesses can use these insights to improve their operations, enhance customer experience, and develop effective marketing strategies. The recommendations are tailored to address specific challenges and opportunities, ensuring that they are relevant and practical.

The research is designed to cater to a diverse audience, including investors, enterprises, consultants, and policymakers. Each group can benefit from the insights provided, whether it is for identifying investment opportunities or developing strategic plans.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/dural-adhesive-agent-for-surgical-market

About Emergen Research
Emergen Research is a leading provider of market research and consulting services, offering data-driven insights and strategic guidance to help businesses succeed in a competitive environment.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com